Interestingly, panobinostat still blocks mTORC1 activation through AA signaling in TSC1 knockout cells stimulated with serum (Fig. 4F), suggesting that panobinostat may be useful for treating TSC disease. Here, TSC1 is linked to tuberous sclerosis.